Clinical trial NCT01326325 - References

Pain — Efficacy of Low Analgesic Doses of Ketamine Associated With Opioids in Refractory Cancer Pain Treatment

Citation(s)

•   Ashby MA, Martin P, Jackson KA
  Opioid substitution to reduce adverse effects in cancer pain management. Med J Aust. 1999 Jan 18;170(2):68-71.
•   Backonja M, Arndt G, Gombar KA, Check B, Zimmermann M
  Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain. 1994 Jan;56(1):51-7. Erratum in: Pain 1994 Sep;58(3):433.
•   Bell R, Eccleston C, Kalso E
  Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev. 2003;(1):CD003351. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD003351.
•   Bell RF
  Low-dose subcutaneous ketamine infusion and morphine tolerance. Pain. 1999 Oct;83(1):101-3.
•   Berger JM, Ryan A, Vadivelu N, Merriam P, Rever L, Harrison P
  Ketamine-fentanyl-midazolam infusion for the control of symptoms in terminal life care. Am J Hosp Palliat Care. 2000 Mar-Apr;17(2):127-34.
•   Cherry DA, Plummer JL, Gourlay GK, Coates KR, Odgers CL
  Ketamine as an adjunct to morphine in the treatment of pain. Pain. 1995 Jul;62(1):119-21.
•   Clark JL, Kalan GE
  Effective treatment of severe cancer pain of the head using low-dose ketamine in an opioid-tolerant patient. J Pain Symptom Manage. 1995 May;10(4):310-4.
•   Clements JA, Nimmo WS
  Pharmacokinetics and analgesic effect of ketamine in man. Br J Anaesth. 1981 Jan;53(1):27-30.
•   DOMINO EF, CHODOFF P, CORSSEN G
  PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN. Clin Pharmacol Ther. 1965 May-Jun;6:279-91.
•   Eide PK, Stubhaug A, Stenehjem AE
  Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation. Neurosurgery. 1995 Dec;37(6):1080-7.
•   Eide PK, Stubhaug A
  Relief of glossopharyngeal neuralgia by ketamine-induced N-methyl-aspartate receptor blockade. Neurosurgery. 1997 Aug;41(2):505-8.
•   Felsby S, Nielsen J, Arendt-Nielsen L, Jensen TS
  NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride. Pain. 1996 Feb;64(2):283-91.
•   Fine PG
  Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain. J Pain Symptom Manage. 1999 Apr;17(4):296-300.
•   Franks NP, Lieb WR
  Molecular and cellular mechanisms of general anaesthesia. Nature. 1994 Feb 17;367(6464):607-14. Review.
•   Jackson K, Ashby M, Martin P, Pisasale M, Brumley D, Hayes B
  "Burst" ketamine for refractory cancer pain: an open-label audit of 39 patients. J Pain Symptom Manage. 2001 Oct;22(4):834-42.
•   Jacox A, Carr DB, Payne R
  New clinical-practice guidelines for the management of pain in patients with cancer. N Engl J Med. 1994 Mar 3;330(9):651-5.
•   Kanamaru T, Saeki S, Katsumata N, Mizuno K, Ogawa S, Suzuki H
  [Ketamine infusion for control of pain in patients with advanced cancer]. Masui. 1990 Oct;39(10):1368-71. Japanese.
•   Kannan TR, Saxena A, Bhatnagar S, Barry A
  Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients. J Pain Symptom Manage. 2002 Jan;23(1):60-5.
•   Krakowski I, Theobald S, Balp L, Bonnefoi MP, Chvetzoff G, Collard O, Collin E, Couturier M, Delorme T, Duclos R, Eschalier A, Fergane B, Larue F, Magnet M, Minello C, Navez ML, Richard A, Richard B, Rostaing-Rigattieri S, Rousselot H, Santolaria N, Torloting G, Toussaint S, Vuillemin N, Wagner JP, Fabre N; FNCLCC
  Summary version of the Standards, Options and Recommendations for the use of analgesia for the treatment of nociceptive pain in adults with cancer (update 2002). Br J Cancer. 2003 Aug;89 Suppl 1:S67-72.
•   Lauretti GR, Lima IC, Reis MP, Prado WA, Pereira NL
  Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management. Anesthesiology. 1999 Jun;90(6):1528-33.
•   Lloyd-Williams M
  Ketamine for cancer pain. J Pain Symptom Manage. 2000 Feb;19(2):79-80.
•   Max MB, Byas-Smith MG, Gracely RH, Bennett GJ
  Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: a double-blind comparison to alfentanil and placebo. Clin Neuropharmacol. 1995 Aug;18(4):360-8.
•   McQueen AL, Baroletti SA
  Adjuvant ketamine analgesia for the management of cancer pain. Ann Pharmacother. 2002 Oct;36(10):1614-9. Review. Erratum in: Ann Pharmacother. 2003 Sep;37(9):1346.
•   Mercadante S, Arcuri E, Tirelli W, Casuccio A
  Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study. J Pain Symptom Manage. 2000 Oct;20(4):246-52.
•   Muller A, Lemos D
  [Cancer pain: beneficial effect of ketamine addition to spinal administration of morphine-clonidine-lidocaine mixture]. Ann Fr Anesth Reanim. 1996;15(3):271-6. French.
•   Nikolajsen L, Hansen CL, Nielsen J, Keller J, Arendt-Nielsen L, Jensen TS
  The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input. Pain. 1996 Sep;67(1):69-77.
•   Notcutt WG
  Transporting patients with overwhelming pain. Anaesthesia. 1994 Feb;49(2):145-7.
•   Oshima E, Tei K, Kayazawa H, Urabe N
  Continuous subcutaneous injection of ketamine for cancer pain. Can J Anaesth. 1990 Apr;37(3):385-6.
•   Persson J, Axelsson G, Hallin RG, Gustafsson LL
  Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization. Pain. 1995 Feb;60(2):217-22.
•   Rostaing-Rigattieri S, Rousselot H, Krakowski I, Theobald S, Collin E, Vuillemin N, Balp L, Torloting G, Fergane B, Richard B, Duclos R, Eschalier A, Delorme T, Minello C, Toussaint S, Richard A, Magnet M, Chvetzoff G, Larue F, Navez ML, Collard O, Bonnefoi MP, Couturier M, Santolaria N, Wagner JP, Fabre N
  [Standards, options and recommendations for the use of medical analgesics for the treatment of pain arising from excess nociception in adults with cancer (update 2002): opioid analgesics with the exception of morphine by mouth and the rotation]. Bull Cancer. 2003 Aug-Sep;90(8-9):795-806. French.
•   Shimoyama N, Shimoyama M, Inturrisi CE, Elliott KJ
  Ketamine attenuates and reverses morphine tolerance in rodents. Anesthesiology. 1996 Dec;85(6):1357-66.
•   Sosnowski M
  Pain management: physiopathology, future research and endpoints. Support Care Cancer. 1993 Mar;1(2):79-88. Review.
•   Yamamura T, Harada K, Okamura A, Kemmotsu O
  Is the site of action of ketamine anesthesia the N-methyl-D-aspartate receptor? Anesthesiology. 1990 Apr;72(4):704-10.
•   Yang CY, Wong CS, Chang JY, Ho ST
  Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain. Can J Anaesth. 1996 Apr;43(4):379-83.

Study of the Efficiency of the Ketamine With Low Analgesic Doses, in Association With High Opioids, in the Treatment of the Rebels Pains, in Palliative Phase of the Cancerous Disease

Details for clinical trial NCT01326325